Dall'era, M C <br/><br/>
Type I interferon correlates with serological and clinical manifestations of SLE.  [electronic resource] 

 -  Annals of the rheumatic diseases  Dec 2005 
 - 1692-7 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0003-4967 
<br/><br/><label>Standard No.: </label>10.1136/ard.2004.033753  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Black or African American<br/>Aged<br/>Antibodies, Antinuclear--blood<br/>Biomarkers--blood<br/>Cell Differentiation<br/>Complement C3--analysis<br/>Dendritic Cells--pathology<br/>Female<br/>Humans<br/>Interferon Type I--blood<br/>Interferon alpha-2<br/>Interferon-alpha--pharmacology<br/>Lupus Erythematosus, Systemic--ethnology<br/>Lupus Nephritis--immunology<br/>Lupus Vasculitis, Central Nervous System--immunology<br/>Male<br/>Membrane Proteins--immunology<br/>Middle Aged<br/>Monocytes--drug effects<br/>Receptor, Interferon alpha-beta<br/>Receptors, Interferon--immunology<br/>Recombinant Proteins<br/>Severity of Illness Index